Basis EHR established its first MVP release which subsequently made the system a preference among clinicians thus surpassing ...

This announcement marks the third foundational support pillar for Tevogen.AI, the Company’s AI initiative which aims to transform precision medicine: Microsoft Research – contributing digital ...

Perkins Coie LLP and Reed Smith LLP are serving as legal counsel to RadNet in connection with the transaction. Piper Sandler & Co. is serving as financial advisor to iCAD and Dentons LLP is serving as ...

POPULUS Health Technologies today announced that Edith Hodkinson has joined as Chief Strategy Officer. Edith brings over 25 years of experience in the healthcare industry leading digital innovation ...

Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused ...

In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope ...

BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a diversified biotechnology and specialty materials group headquartered in Malaysia and incorporated in Wyoming, today announced ...

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces the promotion of Donovan Quill to chief strategy officer, Life ...

Artios Pharma Limited (“Artios”), a clinical-stage biotech company led by pioneers of DNA damage response (“DDR”) drug development, today announced that the company’s abstract featuring clinical trial ...

Mr. Demurjian will participate in the panel discussion titled "The Good, the Bad and the Ugly: How to Approach Investors" scheduled for 8:05 - 8:50 a.m. PT on Friday, April 25. As CEO of Aspargo Labs ...

Dr. Young’s presentation, titled “Applying Principles of FDA’s Project Optimus to Oncology and Non-Oncology Rare Diseases,” will take place on Tuesday, April 24, 2025, at 2:00 p.m. Eastern Time at the ...

REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers ...